← Open Payments lookup

AJIRIOGHENE IGBIDE: Open Payments

NPI 1659610871 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$501 in 21 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $501

Food & beverage: $473Education: $27
CompanyPaymentsAmount
Lundbeck LLC11$260
Otsuka America Pharmaceutical, Inc.5$111
Teva Pharmaceuticals USA, Inc.2$38
Neurocrine BioSciences, Inc.1$37
Janssen Pharmaceuticals, Inc1$27
E.R. Squibb & Sons, L.L.C.1$27

Products named: REXULTI, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA, COBENFY.

Industry payments across DC — which companies pay providers there.